BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
Tenpoint and Visus Therapeutics merge with plans for ophthalmic therapeutic advancements

Tenpoint and Visus Therapeutics merge with plans for ophthalmic therapeutic advancements

Newly-combined Tenpoint Therapeutics, Ltd includes a pipeline featuring BRIMOCHOL PF, a once-daily eye drop for presbyopia targeting an NDA filing in 2025.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
EyeMD EMR's patient engagement system targets workflow efficiency
EyeMD EMR's patient engagement system targets workflow efficiency
Optase's Allegro Eye Drops target environmental irritant relief
Optase's Allegro Eye Drops target environmental irritant relief
Lumenis's OptiPLUS delivers clinically significant results for DED
Lumenis's OptiPLUS delivers clinically significant results for DED
Ophthalmology Tech Forum to showcase groundbreaking industry innovations
Ophthalmology Tech Forum to showcase groundbreaking industry innovations
Watch More
Business
Tenpoint and Visus Therapeutics merge with plans for ophthalmic therapeutic advancements
Tenpoint and Visus Therapeutics merge with plans for ophthalmic therapeutic advancements
Bausch + Lomb purchases Elios Vision
Bausch + Lomb purchases Elios Vision
SCOPE Health and CEVR partner to develop DED and OSD tech
SCOPE Health and CEVR partner to develop DED and OSD tech
Avant Technologies and Ainnova to advance low-cost retinal camera with AI software
Avant Technologies and Ainnova to advance low-cost retinal camera with AI software
Research
ViaLase and Moran Eye Center launch glaucoma research partnership
ViaLase and Moran Eye Center launch glaucoma research partnership
How reliable are VR devices for visual field testing?
How reliable are VR devices for visual field testing?
ARPA-H invests in four research teams for eye transplant project
ARPA-H invests in four research teams for eye transplant project
Study proposes new severity scale for diabetic macular ischemia
Study proposes new severity scale for diabetic macular ischemia
Pipeline
Galimedix kicks off phase 1 study on oral therapy for ocular neurodegenerative diseases
Galimedix kicks off phase 1 study on oral therapy for ocular neurodegenerative diseases
EyePoint doses first patient in second phase 3 trial of DURAVYU for wet AMD
EyePoint doses first patient in second phase 3 trial of DURAVYU for wet AMD
Melt reports favorable phase 3 data on preop procedural sedation tablet
Melt reports favorable phase 3 data on preop procedural sedation tablet
Adverum reports extended 4-year findings on wet AMD gene therapy
Adverum reports extended 4-year findings on wet AMD gene therapy
Products
Nidek's NP-T Preloaded Toric IOL Injection System makes global debut
Nidek's NP-T Preloaded Toric IOL Injection System makes global debut
Regener-Eyes launches new preservative-free bottles with backflow prevention
Regener-Eyes launches new preservative-free bottles with backflow prevention
FDA clears Novoxel's Tixel device for evaporative dry eye due to MGD
FDA clears Novoxel's Tixel device for evaporative dry eye due to MGD
Alcon unveils Total30 for Astigmatism expanded parameters
Alcon unveils Total30 for Astigmatism expanded parameters
Legal
FTC refunds over $1M to bait-and-switch LASIKPlus consumers
FTC refunds over $1M to bait-and-switch LASIKPlus consumers
Updated Eyeglass Rule officially takes effect
Updated Eyeglass Rule officially takes effect
FTC supports proposed FDA interchangeable biosimilar drug guidance
FTC supports proposed FDA interchangeable biosimilar drug guidance
LumiThera receives first CPT code for retina-based PBM therapy
LumiThera receives first CPT code for retina-based PBM therapy
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Events
Eyes On 2025 showcases the industry's upcoming innovations
Eyes On 2025 showcases the industry's upcoming innovations
AOAExcel to host financial wellness workshop for optometrists
AOAExcel to host financial wellness workshop for optometrists
Foundation Fighting Blindness to host webinar on IRDs, low vision
Foundation Fighting Blindness to host webinar on IRDs, low vision
Eyes On Retina 2024 features hot topics and global attendees
Eyes On Retina 2024 features hot topics and global attendees
Browse All Stories »